RENAL TRANSPLANT
Clinical trials for RENAL TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new RENAL TRANSPLANT trials appear
Sign up with your email to follow new studies for RENAL TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney transplant patients may think clearer with once-daily pill switch
Disease control CompletedThis study looked at 56 stable kidney transplant patients to see if switching their anti-rejection medication from twice-daily tacrolimus to once-daily Envarsus XR improved their thinking skills and quality of life. Participants took tests of memory, attention, and reasoning befo…
Matched conditions: RENAL TRANSPLANT
Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug aims to stop kidney disease from coming back after transplant
Disease control CompletedThis phase 2 study tested a drug called pegcetacoplan in 13 kidney transplant patients whose original kidney disease (C3G or IC-MPGN) had come back. The goal was to see if the drug could reduce signs of disease activity in the kidney. The study was small and early-stage, so resul…
Matched conditions: RENAL TRANSPLANT
Phase: PHASE2 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Scientists probe immune cells to predict transplant rejection
Knowledge-focused CompletedThis completed study looked at 116 kidney transplant patients to understand how B cells (a type of immune cell) behave in those who develop donor-specific antibodies or chronic rejection. Researchers analyzed blood samples to find patterns that could serve as early warning signs.…
Matched conditions: RENAL TRANSPLANT
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Kidney transplant study compares immune effects of two common drugs
Knowledge-focused CompletedThis study looked at 49 kidney transplant patients to see how two different induction therapies—thymoglobulin and basiliximab—affect B cells, a type of immune cell. Researchers compared the B cell profiles between the two groups and with data from patients who had chronic antibod…
Matched conditions: RENAL TRANSPLANT
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC